Yi Chai

Research Assistant Professor @HKUMed

[Eric YF Wan @EricWan_HKU]

Our study in @BMCMedicine showed a significant increase in the risk of multiple disease outcomes associated with the severity of COVID-19 infection, both during the acute and post-acute phases. https://t.co/Jr2CqD8Cr9

[BMC Medicine @BMCMedicine]

Assessment of COVID-19 with complications post acute phase.
Read the full study from @EricWan_HKU @Ranzhang_hku @Sukrit_Mathur99 @VincentKCYan @FranciscoTTLai1 @ChuiCeline @snowly12191 @CarlosWongHKU @Esther_CSMPRHKU @Ian_HKU and colleagues here: https://t.co/4WDZX95xMF

[Ivan Lam @IVANCHLAM]

Study in @BMCMedicine showed the significant increased risk of multiple disease outcomes with increasing severity in both acute and post-acute phases of #Covid_19 infection, especially among elderly population.
https://t.co/J4eFpM0aNS

[Celine Chui HKU @ChuiCeline]

Our study using self-controlled case series study showed no increased risk of neuropsychiatric events after fluoroquinolones exposure, with amoxiclav as the active comparator. @hku_son @hkumed @HKU_SPH @HKU_D24H @LSHTM @CSMPR_HKUPharm

https://t.co/HDO7Eow66L

[Prof Ian Wong @Prof_IanWong]

Our study reveals persistently elevated rates of psychotropic drug prescriptions beyond the initial phase of the pandemic among patients with depression and anxiety in the post-pandemic era. The Lancet Psychiatry https://t.co/YGohE2iZ6H

[JAMA Network Open @JAMANetworkOpen]

Extending early intervention services (EASY Plus) for patients with first-episode schizophrenia aged 15-64 in Hong Kong was associated with reduced self-harm and suicide rates over 20 years, this study finds. https://t.co/G0zHEE8fMR

[CSMPR_HKU @CSMPR_HKUPharm]

Study by @Yi_Chai18 found that early intervention services #EIS was associated with reduced #selfharm and #suicide rates among all patients with first-episode #schizophrenia #FES.

Full study: https://t.co/dnSrPZAsUS

@HkuPharm #CSMPR #HKU #HKUMed #HKUPharm #pharmacy #research

[Eric YF Wan @EricWan_HKU]

Our amazing work on a seemingly simple but important evidence in @AnnalsofIM that statins work well even in old people aged ≥ 85 yrs. Thanks awesome students @Wanchun_Xu, Amanda, supervisor @CindyLan897569 and @HarvardChanSPH collaborator @GDanaei.

https://t.co/H3MSieiHNY

[Shirley Xue Li @snowly12191]

Our work ⁦@BMCMedicine⁩ found 21% of depression incidence increasing during the pandemic but 11-16% less health service used compared with pre-pandemics. The system is recovering with service rebound over 3 years.⁦@HkuPharm⁩ ⁦@Ian_HKU⁩ https://t.co/vD37eWKs7P

[Celine Chui HKU @ChuiCeline]

P-CARDIAC secondary model's paper is finally out! A 10-year CVD risk prediction model for Chinese with established CVD risk. Go check out the article available on @escardio @ESC_Journals #EHJDigitalHealth #P_CARDIAC @hkumed @hku_son @HkuPharm

https://t.co/rSKSkR2MVP

[Le GAO @legao0513]

Our study involving 3.6m mother-child pairs in
@NatureMedicine suggests no direct causal relationship between gestational diabetes and ADHD. Instead, it highlights the importance of considering a holistic risk profile like shared genetic/familial factors.
https://t.co/Fmq3vSmDQS

[Yi Chai @Yi_Chai18]

Our recent study using CDM on @CambridgeCore finds immediate declines in mental health diagnoses following population-wide COVID-19 restrictions in France, Germany, Italy, UK, and US. https://t.co/TxNk3QOoSC
#COVID19
#mentalillness
@Ian_HKU @KennethKCMan @wallis_lau @HaoLuo429

[Ivan Lam @IVANCHLAM]

Our study @NatureComms showed a progressive reduction in risk of clinical outcomes following COVID-19 infection and the effect of COVID-19 vaccination in reducing the risk and its persistence.
https://t.co/I9giSw5YXI
#LongCovid #COVID19
@Ian_HKU
@EricWan_HKU
@Ranzhang_hku